FACTOR-XIII CONCENTRATE FOR PROPHYLAXIS OF REBLEEDING IN SUBARACHNOID HEMORRHAGE (SAH) - RESULTS OF A PROSPECTIVE MULTICENTER PILOT-STUDY

被引：0
|
作者：
THIE, A
HENZE, T
DEGNER, D
OBERLING, M
CLEMENS, R
KLEIN, HJ
LOMBARD, GF
机构：
[1] UNIV GOTTINGEN,NEUROL KLIN,D-3400 GOTTINGEN,FED REP GER
[2] BEHRINGWERKE AG,D-3550 MARBURG,FED REP GER
[3] UNIV TURIN,NEUROCHIRURG KLIN,I-10124 TURIN,ITALY
[4] SPANISH HOSP,BUENOS AIRES,ARGENTINA
[5] BEZIRKSKRANKENHAUS GUNZBURG,GUNZBURG,FED REP GER
[6] EV STIFT ST MARTIN,KOBLENZ,FED REP GER
[7] UNIV HAMBURG,NEUROL KLIN,D-2000 HAMBURG 13,FED REP GER
来源：
THROMBOSIS AND HAEMOSTASIS | 1987年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 10 条
  • [1] FACTOR-XIII CONCENTRATE FOR PREVENTION OF RECURRENT SUBARACHNOID HEMORRHAGE - RESULTS OF A MULTICENTER PILOT-STUDY
    THIE, A
    HENZE, T
    NEUROCHIRURGIA, 1991, 34 (04) : 107 - 110
  • [2] FACTOR-XIII CONCENTRATE FOR PROPHYLAXIS OF CICATRIZATION DISORDERS IN HIGH-RISK PATIENTS - DOUBLE-BLIND-STUDY
    SCHRAMM, W
    SCHMIDTLER, R
    WALDMANN, H
    MARX, R
    BLUT, 1980, 40 (01): : 74 - 74
  • [3] Intracranial Venous Alteration in Patients With Aneurysmal Subarachnoid Hemorrhage: Protocol for the Prospective and Observational SAH Multicenter Study (SMS)
    Umana, Giuseppe E.
    Tomasi, S. Ottavio
    Palmisciano, Paolo
    Scalia, Gianluca
    Da Ros, Valerio
    Al-Schameri, Rahman
    Priola, Stefano M.
    Brunasso, Lara
    Giammalva, Giuseppe Roberto
    Paolini, Federica
    Costanzo, Roberta
    Bonosi, Lapo
    Gerardi, Rosa Maria
    Maugeri, Rosario
    Strigari, Lidia
    Stieg, Philip E.
    Esposito, Giuseppe
    Lawton, Michael T.
    Griessenauer, Christoph J.
    Winkler, Peter A.
    FRONTIERS IN SURGERY, 2022, 9
  • [4] SUBSTITUTION WITH F-XIII CONCENTRATE IN THERAPY-RESISTANT ULCERATIVE-COLITIS - A PROSPECTIVE PILOT-STUDY
    LORENZ, R
    BORN, P
    CLASSEN, M
    MEDIZINISCHE KLINIK, 1994, 89 (10) : 534 - 537
  • [5] SUBSTITUTION WITH F-XIII CONCENTRATE IN THERAPY-RESISTANT ULCERATIVE-COLITIS - A PROSPECTIVE PILOT-STUDY (VOL 89, PG 534, 1994)
    LORENZ, R
    BORN, P
    CLASSEN, M
    MEDIZINISCHE KLINIK, 1994, 89 (12) : 692 - 692
  • [6] Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study
    Nugent, Diane
    THROMBOSIS RESEARCH, 2012, 130 : S12 - S14
  • [7] Treatment of Spontaneous Subarachnoid Hemorrhage and Self-Reported Neuropsychological Performance at 6 Months - Results of a Prospective Clinical Pilot Study on Good-Grade Patients
    Bruendl, Elisabeth
    Schoedel, Petra
    Bele, Sylvia
    Proescholdt, Martin
    Scheitzach, Judith
    Zeman, Florian
    Brawanski, Alexander
    Schebesch, Karl-Michael
    TURKISH NEUROSURGERY, 2018, 28 (03) : 369 - 388
  • [8] Family history of postpartum hemorrhage is a risk factor for postpartum hemorrhage after vaginal delivery: results from the French prospective multicenter Haemorrhages and Thromboembolic Venous Disease of the Postpartum cohort study
    Anouih, Francois
    de Moreuil, Claire
    Tremouilhac, Christophe
    Jacquot, Matthieu
    Salnelle, Gilles
    Bellec, Violaine
    Touffet, Nathalie
    Cornec, Caroline
    Muller, Matthieu
    Dupre, Pierre-Francois
    Bellot, Charles
    Morcel, Karine
    Le Joliff, Delphine
    Drugmanne, Guillaume
    Gelebart, Elodie
    Lucier, Sandy
    Nowak, Emmanuel
    Bihan, Line
    Couturaud, Francis
    Tromeur, Cecile
    Le Moigne, Emmanuelle
    Pan-Petesch, Brigitte
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2023, 5 (09)
  • [9] Potential role of serum hypoxia-inducible factor 1alpha as a biomarker of delayed cerebral ischemia and poor clinical outcome after human aneurysmal subarachnoid hemorrhage: A prospective, longitudinal, multicenter, and observational study
    Cai, Ye-Yan
    Zhuang, Yao-Kun
    Wang, Wen-Jian
    Jiang, Feng
    Hu, Jie-Miao
    Zhang, Xiao-Le
    Zhang, Li-Xin
    Lou, Xiao-Hui
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] ISOLATED PERFUSION OF THE LIMB WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA), INTERFERON-GAMMA (IFN-GAMMA) AND MELPHALAN FOR MELANOMA STAGE-III - RESULTS OF A MULTICENTER PILOT-STUDY
    LIENARD, D
    EGGERMONT, AMM
    KOOPS, HS
    KROON, BBR
    ROSENKAIMER, F
    AUTIER, P
    LEJEUNE, FJ
    MELANOMA RESEARCH, 1994, 4 : 21 - 26
1